Clinical Trial Update: Fruquintinib as a Maintenance Therapy Following First-line Treatment for Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Fruquintinib as maintenance therapy after first-line treatment for metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Fruquintinib (fruquintinib)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Colo-rectal Cancer | Phase 2 | Status: UNKNOWN